Using enzymes to improve chemical reactions for better products
Trapping reactive intermediates and their application towards catalysis
This study is looking at special enzymes that help turn simple chemicals into more useful ones, with the goal of making it easier and cheaper to create important medicines and other products that could benefit patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11007163 on NIH RePORTER |
What this research studies
This research focuses on understanding how certain enzymes, specifically monooxygenases, can be used to enhance chemical reactions that convert simple hydrocarbons into more complex and valuable molecules. By studying the electronic properties of these enzymes, the researchers aim to develop new synthetic catalysts that mimic their function. This could lead to more efficient methods for producing pharmaceuticals and other important chemicals from inexpensive raw materials. Patients may benefit indirectly through improved drug development and production processes.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals who rely on pharmaceuticals derived from complex chemical processes.
Not a fit: Patients who do not use pharmaceuticals or are not affected by advancements in chemical synthesis may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and cost-effective production of pharmaceuticals and other valuable chemicals.
How similar studies have performed: Other research has shown success in using enzyme mimetics for catalysis, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: Betley, Theodore a — Harvard University
- Study coordinator: Betley, Theodore a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.